Samsung Biologics signs 426 bln-won land purchase deal to build 2nd campus

Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, on Monday signed a land purchase contract worth 426 billion won (US$323 million) to build a second campus inside a free economic zone west of Seoul.